PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - Giugliano, Robert P.
ED  - Blazing, Michael A.
TI  - IMPROVE-IT Findings
DP  - 2015 Nov 21
TA  - MD Conference Express
PG  - 21--22
VI  - 15
IP  - 28
4099  - http://mdc.sagepub.com/content/15/28/21.short
4100  - http://mdc.sagepub.com/content/15/28/21.full
AB  - The IMPROVE-IT trial showed that the cholesterol-lowering drug ezetimibe, when added to simvastatin, provides greater improvement in cardiovascular outcomes among patients with diabetes vs those without diabetes in a population with acute coronary syndrome. Additionally, the rate of new-onset diabetes was not increased among patients treated with ezetimibe.